Cargando…
Fabry disease: Evidence for a regional founder effect of the GLA gene mutation 30delG in Brazilian patients
The Fabry disease is caused by mutations in the gene (GLA) that encodes the enzyme α-galactosidase A (α-Gal A). More than 500 pathologic variants of GLA have already been described, most of them are family-specific. In southern Brazil, a frequent single-base deletion (GLA 30delG) was identified amon...
Autores principales: | de Alencar, Dayse Oliveira, Netto, Cristina, Ashton-Prolla, Patricia, Giugliani, Roberto, Ribeiro-dos-Santos, Ândrea, Pereira, Fernanda, Matte, Ursula, Santos, Ney, Santos, Sidney |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121364/ https://www.ncbi.nlm.nih.gov/pubmed/27896116 http://dx.doi.org/10.1016/j.ymgmr.2014.09.002 |
Ejemplares similares
-
Impact of enzyme replacement therapy and hematopoietic stem cell therapy on growth in patients with Hunter syndrome
por: Patel, Pravin, et al.
Publicado: (2014) -
Phenylketonuria (PKU): A problem solved?
por: Brown, Christine S., et al.
Publicado: (2015) -
Expanding the spectrum of HEXA mutations in Indian patients with Tay–Sachs disease
por: Sheth, Jayesh, et al.
Publicado: (2014) -
Genotypic and bioinformatic evaluation of the alpha-l-iduronidase gene and protein in patients with mucopolysaccharidosis type I from Colombia, Ecuador and Peru
por: Pineda, Tatiana, et al.
Publicado: (2014) -
Effects of intracerebroventricular administration of 2-hydroxypropyl-β-cyclodextrin in a patient with Niemann–Pick Type C disease
por: Matsuo, Muneaki, et al.
Publicado: (2014)